Author

Kilsun Kim

Oregon Health & Science University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anandarao MunakalaiD· 1 shared Ashok P. ReddyiD· 1 shared Bingbing X. LiiD· 1 shared Keith D. ZientekiD· 1 shared Phillip A. WilmarthiD· 1 shared Warren, Julia, MD, PhD· 1 shared Xiangshu XiaoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anandarao MunakalaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of clofibric acid as a SYVN1 ligand for PROTAC development

Warren, Julia, MD, PhD, Anandarao Munakala, Keith D. Zientek, Kilsun Kim, Phillip A. Wilmarth, Ashok P. Reddy, Bingbing X. Li, Xiangshu Xiao

This paper identifies clofibric acid as a SYVN1 ligand and demonstrates its use in developing SYVN1-dependent BRD4 PROTACs with improved degradation efficiency.

bioRxiv · Jan 28, 2026 · PreprintPharmacology & Toxicology